NOVELION THERAPEUTICS INC. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$130.4M

Net Income/Loss (FY2018)

-$108.3M

Total Assets (FY2018)

$341.7M

Total Equity (FY2018)

-$88.9M

Cash Flows from Operating Activities (FY2018)

-$55.5M

Source: NOVELION THERAPEUTICS INC. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.